For safety, its crucial to gradually withdraw immunosuppression in select patients with lupus nephritis who have clear evidence of histological, clinical, and immunological disease remission. Stopping ...
The last time I wrote an article on Eledon Pharmaceuticals, Inc. (ELDN) it was with respect to a Seeking Alpha article entitled "Eledon: Changing Scope Of Immunosuppressive Drug Space With Tegoprubart ...
Add Yahoo as a preferred source to see more of our stories on Google. Thermo Fisher has committed to a $125m payment in January 2027. Credit: JHVEPhoto / Shutterstock.com. (JHVEPhoto / ...
IgA nephropathy, first described in 1968 by Berger and Hinglais, 1 is the most common form of primary glomerulonephritis. For decades, IgA nephropathy was considered to have a relatively good ...
David Quan, PharmD, pharmacy supervisor at UCSF Pharmaceutical Services, shows the many bottles of medication are commonly prescribed for kidney transplant patients at discharge. Photo by Susan ...
Optimized immunosuppressive regimens support the survival of transplanted iPSC-CMs without immune rejection, advancing safer regenerative therapies for severe heart failure. While current clinical ...
Patients undergoing intensive chemotherapy or hematopoietic stem-cell transplant often experience neutropenia, leaving them highly vulnerable to infection. 1,2 Standard precautionary advice has long ...
When the FDA reworked the prescribing information for Sarepta Therapeutics' Duchenne muscular dystrophy (DMD) gene therapy Elevidys earlier this month, the company touted a plan to study a regimen ...
Benlysta is an immunosuppressant medication that can lower the amount of antibodies your immune system produces. This makes it effective in managing different forms of lupus. Benlysta works by ...
BROWNSBURG, IN – A medication long known for its use in substance abuse treatment is getting a second life in the world of functional medicine, offering a new approach for people suffering from ...
Lupus nephritis treatment duration and regimens reflect dynamic patient needs. Nearly half of patients with newly diagnosed lupus nephritis (LN) in a US cohort began treatment with an ...